Ocal, N. Et Al. 2025. Analysis of treatment efficacy, tolerability, and survival of patients receiving antifibrotic therapy for progressive nonidiopathic pulmonary fibrosis. Annals of Thoracic Medicine , vol.20, no.2 , 98-107.

Ocal, N., ÇİLLİ, A., Mogulkoc, N., COŞKUN, N. F., URSAVAŞ, A., HANTA, İ., ... Ozyurek, B. A.(2025). Analysis of treatment efficacy, tolerability, and survival of patients receiving antifibrotic therapy for progressive nonidiopathic pulmonary fibrosis. Annals of Thoracic Medicine , vol.20, no.2, 98-107.

Ocal, Nesrin Et Al. "Analysis of treatment efficacy, tolerability, and survival of patients receiving antifibrotic therapy for progressive nonidiopathic pulmonary fibrosis," Annals of Thoracic Medicine , vol.20, no.2, 98-107, 2025

Ocal, Nesrin Et Al. "Analysis of treatment efficacy, tolerability, and survival of patients receiving antifibrotic therapy for progressive nonidiopathic pulmonary fibrosis." Annals of Thoracic Medicine , vol.20, no.2, pp.98-107, 2025

Ocal, N. Et Al. (2025) . "Analysis of treatment efficacy, tolerability, and survival of patients receiving antifibrotic therapy for progressive nonidiopathic pulmonary fibrosis." Annals of Thoracic Medicine , vol.20, no.2, pp.98-107.

@article{article, author={Nesrin Ocal Et Al. }, title={Analysis of treatment efficacy, tolerability, and survival of patients receiving antifibrotic therapy for progressive nonidiopathic pulmonary fibrosis}, journal={Annals of Thoracic Medicine}, year=2025, pages={98-107} }